Toward closing the loop: An update on insulin pumps and continuous glucose monitoring systems

Endocrinology and Metabolism Clinics of North America

Volumn 39, Issue 3, 2010, Pages 609-624

  Aye, Tandy ^a   Block, Jen ^a   Buckingham, Bruce ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Artificial pancreas; Closed loop therapy; Continuous glucose monitoring; Insulin pumps; Nocturnal hypoglycemia; Type 1 diabetes

Indexed keywords

ADRENALIN; AMYLIN; CARBOHYDRATE; GLUCAGON; GLUCOSE; HEMOGLOBIN A1C; INSULIN; UNCLASSIFIED DRUG; VIAJECT INSULIN;

ACCURACY; ALGORITHM; BLOOD GLUCOSE MONITORING; CALIBRATION; CARBOHYDRATE INTAKE; CLINICAL TRIAL; CONTINUOUS INFUSION; DIABETES MELLITUS; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; INSULIN PUMP; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT EDUCATION; PHARMACODYNAMICS; PRIORITY JOURNAL; RADIOFREQUENCY; REVIEW; RISK REDUCTION; SENSOR;

EID: 77955739983     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ecl.2010.05.005     Document Type: Review

References (71)

1. Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study. JAMA 2003, 290:2159-2167.
2. Petitti D.B., Klingensmith G.J., Bell R.A., et al. Glycemic control in youth with diabetes: the SEARCH for diabetes in Youth Study. J Pediatr 2009, 155:668-672.
3. Steil G.M., Rebrin K., Darwin C., et al. Feasibility of automating insulin delivery for the treatment of type 1 diabetes. Diabetes 2006, 55:3344-3350.
4. Diabetes Research in Children Network (DIRECNET) Study Group The accuracy of the CGMS in children with type 1 diabetes: results of the diabetes research in children network (DirecNet) accuracy study. Diabetes Technol Ther 2003, 5:781-789.
5. Tansey M.J., Beck R.W., Buckingham B.A., et al. Accuracy of the Modified Continuous Glucose Monitoring (CGMS) sensor in an outpatient setting: results from a Diabetes Research in Children Network (DirecNet) Study. Diabetes Technol Ther 2005, 7:109-114.
6. Wilson D.M., Beck R.W., Tamborlane W.V., et al. The accuracy of the FreeStyle navigator continuous glucose monitoring system in children with type 1 diabetes. Diabetes Care 2007, 30:59-64.
7. DirecNet, Buckingham B., Beck R.W., et al. Continuous glucose monitoring in children with type 1 diabetes. J Pediatr 2007, 151:388-393.
8. Monnier L., Mas E., Ginet C., et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 2006, 295:1681-1687.
9. Brownlee M., Hirsch I.B. Glycemic variability: a hemoglobin A1c-independent risk factor for diabetic complications. JAMA 2006, 295:1707-1708.
10. Kilpatrick E.S., Rigby A.S., Atkin S.L. The effect of glucose variability on the risk of microvascular complications in type 1 diabetes. Diabetes Care 2006, 29:1486-1490.
11. Khalil O.S. Noninvasive glucose measurement technologies: an update from 1999 to the dawn of the new millennium. Diabetes Technol Ther 2004, 6:660-697.
12. Keenan D.B., Mastrototaro J.J., Voskanyan G., et al. Delays in minimally invasive continuous glucose monitoring devices: a review of current technology. Society 2009, 3:1207-1214.
13. Nielsen J.K., Djurhuus C.B., Gravholt C.H., et al. Continuous glucose monitoring in interstitial subcutaneous adipose tissue and skeletal muscle reflects excursions in cerebral cortex. Diabetes 2005, 54:1635-1639.
14. Mauras N., Beck R.W., Ruedy K.J., et al. Lack of accuracy of continuous glucose sensors in healthy, nondiabetic children: results of the Diabetes Research in Children Network (DirecNet) accuracy study. J Pediatr 2004, 144:770-775.
15. Fox L., Beck R., Xing D., et al. Variation of interstitial glucose measurements assessed by continuous glucose monitors in healthy, nonobese, nondiabetic individuals. Diabetes Care 2010, 33:1297-1299.
16. Keenan D.B., Cartaya R., Mastrototaro J.J. Accuracy of a new real-time continuous glucose monitoring algorithm. Society 2010, 4:111-118.
17. Zisser H., Jovanovic L., Khan U., et al. Accuracy of a novel intravascular fluorescent continuous glucose sensor in an 8-hour Outpatient Clinic Feasibility Study. Diabetologia 2009, 52:363.
18. Buckingham B.A., Kollman C., Beck R., et al. Evaluation of factors affecting CGMS calibration. Diabetes Technol Ther 2006, 8:318-325.
19. Garg S.K., Schwartz S., Edelman S.V. Improved glucose excursions using an implantable real-time continuous glucose sensor in adults with type 1 diabetes. Diabetes Care 2004, 27:734-738.
20. Armour J.C., Lucisano J.Y., McKean B.D., et al. Application of chronic intravascular blood glucose sensor in dogs. Diabetes 1990, 39:1519-1526.
21. Renard E., Costalat G., Bringer J. From external to implantable insulin pump, can we close the loop?. Diabetes Metab 2002, 28. 2S19-2S25.
22. O'Connell M.A., Donath S., O'Neal D.N., et al. Glycaemic impact of patient-led use of sensor-guided pump therapy in type 1 diabetes: a randomised controlled trial. Diabetologia 2009, 52:1250-1257.
23. Tamborlane W., Beck R., Laffel L. Continuous glucose monitoring and type 1 diabetes. N Engl J Med 2009, 360:191.
24. Beck R.W., Buckingham B., Miller K., et al. Factors predictive of use and of benefit from continuous glucose monitoring in type 1 diabetes. Diabetes Care 2009, 32:1947-1953.
25. Gilliam L.K., Hirsch I.B. Practical aspects of real-time continuous glucose monitoring. Diabetes Technol Ther 2009, 11(Suppl 1):S75-S82.
26. Hirsch I.B., Armstrong D., Bergenstal R.M., et al. Clinical application of emerging sensor technologies in diabetes management: consensus guidelines for continuous glucose monitoring (CGM). Diabetes Technol Ther 2008, 10:232-244. [quiz: 245-6].
27. Buckingham B., Xing D., Weinzimer S., et al. Use of the DirecNet Applied Treatment Algorithm (DATA) for diabetes management with a real-time continuous glucose monitor (the FreeStyle Navigator). Pediatr Diabetes 2008, 9:142-147.
28. Felig P., Tamborlane W., Sherwin R.S., et al. Insulin-infusion pump for diabetes. N Engl J Med 1979, 301:1004-1005.
29. Burdick J., Chase H.P., Slover R.H., et al. Missed insulin meal boluses and elevated hemoglobin A1c levels in children receiving insulin pump therapy. Pediatrics 2004, 113:e221-e224.
30. El-Khatib F.H., Jiang J., Gerrity R.G., et al. Pharmacodynamics and stability of subcutaneously infused glucagon in a type 1 diabetic Swine model in vivo. Diabetes Technol Ther 2007, 9:135-144.
31. Monsod T.P., Tamborlane W.V., Coraluzzi L., et al. Epipen as an alternative to glucagon in the treatment of hypoglycemia in children with diabetes. Diabetes Care 2001, 24:701-704.
32. Misso M.L., Egberts K.J., Page M., et al. Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus. Cochrane Database Syst Rev 2010, 1. CD005103.
33. Nuboer R., Borsboom G.J., Zoethout J.A., et al. Effects of insulin pump vs. injection treatment on quality of life and impact of disease in children with type 1 diabetes mellitus in a randomized, prospective comparison. Pediatr Diabetes 2008, 9:291-296.
34. Cummins E., Royle P., Snaith A., et al. Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation. Health Technol Assess 2010, 14:1-208.
35. Weinstein R.L., Schwartz S.L., Brazg R.L., et al. Accuracy of the 5-day FreeStyle navigator continuous glucose monitoring system: comparison with frequent laboratory reference measurements. Diabetes Care 2007, 30:1125-1130.
36. Nordquist L., Roxhed N., Griss P., et al. Novel microneedle patches for active insulin delivery are efficient in maintaining glycaemic control: an initial comparison with subcutaneous administration. Pharm Res 2007, 24:1381-1388.
37. Mudaliar S.R., Lindberg F.A., Joyce M., et al. Insulin aspart (B28 asp-insulin): a fast-acting analog of human insulin: absorption kinetics and action profile compared with regular human insulin in healthy nondiabetic subjects. Diabetes Care 1999, 22:1501-1506.
38. Dassau E., Bequette B.W., Buckingham B.A., et al. Detection of a meal using continuous glucose monitoring: implications for an artificial beta-cell. Diabetes Care 2008, 31:295-300.
39. Steiner S.S., Hompesch M., Pohl R., et al. Pharmacokinetics and phrmacodynamics of insulin VIAject and regular human insulin when injected subcutneously directly before a meal in patients with type1 diabetes. Diabetes 2007, 56:A9.
40. Renard E. Implantable closed-loop glucose-sensing and insulin delivery: the future for insulin pump therapy. Curr Opin Pharmacol 2002, 2:708-716.
41. Buckingham B., Block J., Burdick J., et al. Response to nocturnal alarms using a real-time glucose sensor. Diabetes Technol Ther 2005, 7:440-447.
42. Buckingham B., Chase H., Dassau E., et al. Prevention of nocturnal hypoglycemia using predictive alarm algorithms and insulin pump suspension. Diabetes Care 2010, 33:1249-1254.
43. Buckingham B., Cobry E., Clinton P., et al. Preventing hypoglycemia using predictive alarm algorithms and insulin pump suspension. Diabetes Technol Ther 2009, 11:93-97.
44. Buckingham B., Wilson D.M., Lecher T., et al. Duration of nocturnal hypoglycemia prior to seizures. Diabetes Care 2008, 31:2110-2112.
45. Tanenberg R.J., Newton C.A., Drake A.J. Confirmation of hypoglycemia in the dead-in-bed syndrome as captured by a retrospective continuous glucose monitoring system. Endocr Pract 2010, 16:244-248.
46. Steil G.M., Rebrin K., Janowski R., et al. Modeling beta-cell insulin secretion-implications for closed-loop glucose homeostasis. Diabetes Technol Ther 2003, 5:953-964.
47. Parker R.S., Doyle F.J., Peppas N.A. A model-based algorithm for blood glucose control in type I diabetic patients. IEEE Trans Biomed Eng 1999, 46:148-157.
48. Dua P., Doyle F.J., Pistikopoulos E.N. Model based blood glucose control for type 1 diabetes via parametric programming. IEEE Trans Biomed Eng 2006, 53(8):1478-1491.
49. Parker RI, Doyle 3rd FJ. Advanced Model Predictive Control (MPC) for type 1 diabetic patient blood glucose control. In: Proceedings of the American Control Conference. 2000. p. 3483-7.
50. Trajanoski Z., Regittnig W., Wach P. Simulation studies on neural predictive control of glucose using the subcutaneous route. Comput Methods Programs Biomed 1998, 56:133-139.
51. Weinzimer S.A., Steil G.M., Swan K.L., et al. Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas. Diabetes Care 2008, 31:934-939.
52. Bequette B.W. Process control: modeling, design and simulation 2003, Prentice Hall, Upper Saddle River (NJ).
53. Schaller H.C., Schaupp L., Bodenlenz M., et al. On-line adaptive algorithm with glucose prediction capacity for subcutaneous closed loop control of glucose: evaluation under fasting conditions in patients with type 1 diabetes. Diabet Med 2006, 23:90-93.
54. Plank J., Blaha J., Cordingley J., et al. Multicentric, randomized, controlled trial to evaluate blood glucose control by the model predictive control algorithm versus routine glucose management protocols in intensive care unit patients. Diabetes Care 2006, 29:271-276.
55. Bequette B.W. Nonlinear control of chemical processes: a review. Ind Eng Chem Res 1991, 30:1391-1413.
56. Kuure-Kinsey MR, Cutright R, Bequette BW. Computationally efficient neural predictive control based on a feedforward architecture. In: 2006 American Control Conference. Minneapolis (MN), 2006.
57. van den Berghe G., Wouters P., Weekers F., et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001, 345:1359-1367.
58. Piper H.G., Alexander J.L., Shukla A., et al. Real-time continuous glucose monitoring in pediatric patients during and after cardiac surgery. Pediatrics 2006, 118:1176-1184.
59. McCulloch D.K., Barmeier H., Neifing J.L., et al. Metabolic state of the pancreas affects end-point titre in the islet cell antibody assay. Diabetologia 1991, 34:622-625.
60. Hao W., Li L., Mehta V., et al. Functional state of the beta cell affects expression of both forms of glutamic acid decarboxylase. Pancreas 1994, 9:558-562.
61. Hagopian W.A., Karlsen A.E., Petersen J.S., et al. Regulation of glutamic acid decarboxylase diabetes autoantigen expression in highly purified isolated islets from Macaca nemestrina. Endocrinology 1993, 132:2674-2681.
62. Aaen K., Rygaard J., Josefsen K., et al. Dependence of antigen expression on functional state of beta-cells. Diabetes 1990, 39:697-701.
63. Kampe O., Andersson A., Bjork E., et al. High-glucose stimulation of 64,000-Mr islet cell autoantigen expression. Diabetes 1989, 38:1326-1328.
64. Bjork E., Kampe O., Andersson A., et al. Expression of the 64 kDa/glutamic acid decarboxylase rat islet cell autoantigen is influenced by the rate of insulin secretion. Diabetologia 1992, 35:490-493.
65. Bjork E., Kampe O., Karlsson F.A., et al. Glucose regulation of the autoantigen GAD65 in human pancreatic islets. J Clin Endocrinol Metab 1992, 75:1574-1576.
66. Mehta V., Hao W., Brooks-Worrell B.M., et al. The functional state of the beta cell modulates IL-1 and TNF-induced cytotoxicity. Lymphokine Cytokine Res 1993, 12:255-259.
67. Mellado-Gil J.M., Aguilar-Diosdado M. Assay for high glucose-mediated islet cell sensitization to apoptosis induced by streptozotocin and cytokines. Biol Proced Online 2005, 7:162-171.
68. Mellado-Gil J.M., Aguilar-Diosdado M. High glucose potentiates cytokine- and streptozotocin-induced apoptosis of rat islet cells: effect on apoptosis-related genes. J Endocrinol 2004, 183:155-162.
69. Maedler K., Storling J., Sturis J., et al. Glucose- and interleukin-1beta-induced beta-cell apoptosis requires Ca2+ influx and extracellular signal-regulated kinase (ERK) 1/2 activation and is prevented by a sulfonylurea receptor 1/inwardly rectifying K+ channel 6.2 (SUR/Kir6.2) selective potassium channel opener in human islets. Diabetes 2004, 53:1706-1713.
70. Shah S.C., Malone J.I., Simpson N.E. A randomized trial of intensive insulin therapy in newly diagnosed insulin-dependent diabetes mellitus. N Engl J Med 1989, 320:550-554.
71. Weinzimer S., Xing D., Tansey M., et al. FreeStyle navigator continuous glucose monitoring system use in children with type 1 diabetes using glargine-based multiple daily dose regimens: results of a pilot trial Diabetes Research in Children Network (DirecNet) Study Group. Diabetes Care 2008, 31:525-527.